Clinical Trial Update: Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding filgrastim and/or tretinoin to standard chemotherapy improves outcomes in patients with acute myeloid leukemia; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Filgrastim (Neupogen) (filgrastim)
• Tretinoin (All-Trans Retinoic Acid) (tretinoin)

Snippet

Sponsor: Medical Research Council | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 3 | Status: COMPLETED